Transcript Blueprint of a Responsible Pharmaceutical and Private Healthcare Sector

Blueprint of a Responsible
Pharmaceutical and Private
Healthcare Sector
Rudra Shankar
CUTS-International
July 06, 2013
Context
 Capacity Building workshop for medium and large
scale pharmaceutical firms and private hospitals
 The purpose was to facilitate the process of discussion
on responsible ways of doing business
2
Further……….
 To develop understanding on certain technical elements
related to pharmaceutical and private healthcare sector
 Discussion on Challenges faced.
 Role played by various stakeholders in addressing the
challenges
 The workshop was attended by participants from six
states
3
The Writeshop…..
 A ‘writeshop’ was conducted as one of the session
during the workshop.
 The session was aimed at receiving inputs from all the
participants regarding their expectations from various
stakeholders (State government, Regulators, Firms,
Sectoral Associations and Civil Society) related to the
pharma and private healthcare sector along with existing
challenges and the way forward
4
Outline……….
STAKEHOLDERS
State
Government
State Level Firms/Priv Sectoral
Regulators
ate
Associations
Hospitals
Desirable
Actions
Challenges
Way
Forward
5
NGOs,
Academicians
Way Forward……..
 Through the writeshop we came to know about the
challenges facing uptake of business responsibility in
pharmaceutical and private healthcare sector at the state
level.
 We have presented these challenges along with other
information in the form of a discussion paper for all the
participants of the Interface meeting.
6
Continued……
Actors
Challenges
State
Government




…………..
…………..
…………..
…………..
State
Regulators




…………..
…………..
…………..
…………..
State
Associations




…………..
…………..
…………..
…………..
Firms/Privat
e Hospitals




…………..
…………..
…………..
…………..
Civil Society




…………..
…………..
…………..
…………..
Actions


………………
………………
7
Outcomes
Short term Long term

…………

…………
Scheme for adoption of Business
Responsibility
Action: to
overcome
challenges
Challenges:
facing the uptake
of BR in Pharma
& Private
Healthcare
Sector
8
Outcomes:
short term
gains and
long term
benefits
Thank you
9